• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
The Top 10 Global Fine Chemicals Companies: Industry Overview, Key Trends, Growth Strategies, Financial Performance, and SWOT Analysis Product Image

The Top 10 Global Fine Chemicals Companies: Industry Overview, Key Trends, Growth Strategies, Financial Performance, and SWOT Analysis

  • ID: 1241027
  • May 2010
  • Region: Global
  • 133 Pages
  • Scripp Business Insights

FEATURED COMPANIES

  • BASF
  • DSM
  • Evonik Chemicals
  • Johnson Matthey
  • Jubilant Organosys
  • Lanxess (Saltigo)
  • MORE

The history of the fine chemicals industry dates back to the late 18th century, when the early chemical industry was evolved from natural dyes and explosives into modern pharmaceutical products. However, by the end of the 19th century, the commercial production of branded pharmaceuticals flourished in Europe (especially in Germany, as many of the active pharmaceutical ingredients were produced in this
country).

Fine chemicals are generally produced on a large scale, which can be measured in thousands of tonnes per year for certain food additives and drug intermediates. Fine chemicals manufacturing is typically carried out in batch processes, with synthesis being followed by separation and purification steps.

Pharmaceuticals has always been the largest market for the fine chemicals industry. Moreover, it is likely that pharmaceutical intermediates will account for over two-thirds of the fine chemicals market by 2012. Although the number of fine chemicals companies involved in the manufacture of high potency APIs (HPAPIs) has historically been limited, the segment has attracted more companies recently.

Profitability levels have fallen for many fine chemical companies READ MORE >

FEATURED COMPANIES

  • BASF
  • DSM
  • Evonik Chemicals
  • Johnson Matthey
  • Jubilant Organosys
  • Lanxess (Saltigo)
  • MORE

The Top 10 Global Fine Chemicals Companies
Executive summary
Industry overview
BASF
Lonza
DSM
Sumitomo Chemical
Merck KGaA
Lanxess (Saltigo)
Sigma-Aldrich
Jubilant Organosys
Johnson Matthey
Evonik Chemicals

Chapter 1 Introduction
What is this report about?
Methodology

Chapter 2 Industry overview
Summary
Fine chemicals – an overview
Different types of fine chemicals
Pharmaceutical intermediates
Agrochemical intermediates
Flavors and fragrances
Dyes and others
Market dynamics
Size and structure
Profitability
Competitive landscape
Manufacturing standards and their potential benefits
Potential benefits of the guideline
Key partnerships and M&A activity in the fine chemicals sector
Key trends
Advanced technologies
Increasing demand for HPAPIs
Relocation to emerging and fast growing markets
Increasing use of biotechnology and nanotechnology

Chapter 3 BASF
Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Leading supplier of chemical intermediates
Verbund, an innovative approach
Diversified product portfolio
SWOT analysis

Chapter 4 Lonza
Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Chemical manufacturing strengthens Lonza’s technology platform
Partnership with biopharmaceutical and chemical companies
SWOT analysis

Chapter 5 DSM
Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Increasing R&D activity in emerging markets
Microreactors: a new technology for pharmaceutical production
SWOT analysis

Chapter 6 Sumitomo Chemical
Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Strong progress in major R&D projects
Pursuing a new strategy of creative hybrid chemistry
Strong response to the EU’s REACH legislation for chemicals
Creation of next-generation chemical safety information management database
SWOT analysis

Chapter 7 Merck KGaA Chemicals
Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Merck KGaA and Millipore partnership for specialty products
New pharmaceutical production plant to increase Merck KGaA’s capacity in
Germany
Stronger presence in India through acquisition of Bangalore Genei
Merck Serono to build its R&D operations in China
SWOT analysis

Chapter 8 Lanxess (Saltigo)
Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Expansion in BRIC countries
Advanced Intermediates segment
Custom manufacturing
SWOT analysis

Chapter 9 Sigma-Aldrich
Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Strong focus on emerging markets
Partnerships and alliances
Targeting the high-growth biology segment
SWOT analysis

Chapter 10 Jubilant Organosys
Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Integrated business model
Strong R&D and manufacturing services for intermediates and APIs
Positioning as an outsourcing partner of choice
SWOT analysis

Chapter 11 Johnson Matthey
Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Johnson Matthey’s Sustainability 2017 initiative
Strong market position in APIs and contract manufacturing services
SWOT analysis

Chapter 12 Evonik Chemicals
Summary
Company overview
Business segmentation
R&D focus
Financial performance
Growth strategies
Specialty chemicals remain a key focus area for Evonik
Strong commitment to custom manufacturing business
SWOT analysis
Chapter 13 Other major players
Boehringer Ingelheim
Company overview
Recent financial performance
Divis Laboratories
Company overview
Recent financial performance
Pfizer CentreSource
Company overview
Recent financial performance
Cambrex
Company overview
Recent financial performance
Fabbrica Italiana Sintetici
Company overview
Recent financial performance
Appendix
Glossary
Index

List of Figures

Figure 2.1: Fine chemicals and their usage
Figure 3.2: BASF SWOT analysis
Figure 4.3: Lonza business divisions
Figure 4.4: Lonza SWOT analysis
Figure 5.5: DSM business focus
Figure 5.6: DSM SWOT analysis
Figure 6.7: Sumitomo Chemical research laboratories
Figure 6.8: Sumitomo Chemical SWOT analysis
Figure 7.9: Merck KGaA Chemicals SWOT analysis
Figure 8.10: Saltigo SWOT analysis
Figure 9.11: Sigma-Aldrich SWOT analysis
Figure 10.12: Jubilant Organosys business segmentation
Figure 10.13: Jubilant Organosys SWOT analysis
Figure 11.14: Johnson Matthey business segmentation
Figure 11.15: Johnson Matthey SWOT analysis
Figure 12.16: Evonik Chemicals SWOT analysis

List of Tables

Table 2.1: Global fine chemicals market size, 2009–2015
Table 2.2: Leading 10 global fine chemicals companies, 2009
Table 3.3: BASF snapshot
Table 3.4: BASF financial performance by segment, 2009
Table 3.5: BASF chemical sales performance, 2009
Table 4.6: Lonza snapshot
Table 4.7: Lonza financial performance by operating segments, 2009
Table 5.8: DSM snapshot
Table 5.9: DSM key launches in 2009
Table 5.10: DSM R&D expenditure, 2009
Table 5.11: DSM financial performance by segment, 2009
Table 5.12: DSM fine chemicals performance by segment, 2009
Table 6.13: Sumitomo Chemical snapshot
Table 6.14: Sumitomo Chemical financial performance by operating segments, FY 2008
Table 6.15: Sumitomo Chemical financial performance during FY 2004–2008
Table 7.16: Merck KGaA Chemicals snapshot
Table 7.17: Merck KGaA sales performance, 2009
Table 7.18: Merck KGaA Chemicals segmentation sales performance, 2009
Table 8.19: Lanxess (Saltigo) snapshot
Table 8.20: Lanxess financial performance by operating segments, 2009
Table 9.21: Sigma-Aldrich snapshot
Table 9.22: Sigma-Aldrich financial performance by operating segments, 2009
Table 10.23: Jubilant Organosys snapshot
Table 10.24: Jubilant Organosys financial performance by operating segments, FY 2009
Table 10.25: Jubilant Organosys financial performance during FY 2005–2009
Table 10.26: PLSPS revenue distribution by segments, FY 2009
Table 10.27: CRAMS revenue distribution by segments, FY 2009
Table 11.28: Johnson Matthey snapshot
Table 11.29: Johnson Matthey financial performance by operating segments, FY 2008
Table 12.30: Evonik Industries snapshot
Table 12.31: Evonik Industries financial performance by operating segments, 2009
Table 12.32: Evonik Chemicals financial performance by segments, 2009
Table 13.33: Boehringer Ingelheim snapshot
Table 13.34: Boehringer Ingelheim financial performance by operating segments, 2009
Table 13.35: Divis Laboratories snapshot
Table 13.36: Divis Laboratories financial performance, FY 2008
Table 13.37: Pfizer CentreSource snapshot
Table 13.38: Cambrex snapshot
Table 13.39: Cambrex segmental revenue, 2009
Table 13.40: Fabbrica Italiana Sintetici snapshot

- BASF
- Lonza
- DSM
- Sumitomo Chemical
- Merck KGaA Chemical
- Lanxess (Saltigo)
- Sigma-Aldrich
- Jubilant Organosys
- Johnson Matthey
- Evonik Chemicals

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos